K

Kezar Life Sciences

KZR

0.63350
USD
-0.0165
(-2.54%)
Market Closed
Volume
583
EPS
0
Div Yield
0
P/E
-1
Market Cap
56,961,605
Related Instruments
RSG
3.220
(1.66%)
197.500 USD
S
SAR
-0.290
(-1.24%)
23.050 USD
News

Title: Kezar Life Sciences

Sector: Healthcare
Industry: Biotechnology
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.